13F-HR/A filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR/A for the quarter ended 2026-03-31, filed 2026-05-28, with 45 holding rows worth $493,809,335.
- Accession
- 0001791827-26-000004
- Filer
- CIK 1791827
- Filed
- 2026-05-28
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, amendment of type new holdings, 45 entries on the cover page, a total value of $493,809,335 stated on the cover page (in dollars after the unit check, H1), rows summing to $493,809,335 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,104,184 | $176,583,121 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,288,948 | $87,236,001 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 760,424 | $37,298,797 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 6,049,999 | $25,228,496 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,400,708 | $19,679,947 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 400,000 | $15,680,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 450,100 | $13,557,012 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 4,998,267 | $13,095,460 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 77,800 | $9,166,396 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 70,000 | $8,725,500 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 100,000 | $8,665,000 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 950,000 | $8,512,000 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 468,566 | $8,382,646 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 6,699,411 | $7,436,346 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 90,000 | $5,652,000 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 42,000 | $4,062,660 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 60,000 | $3,765,000 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 215,934 | $3,452,785 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 20,000 | $2,787,400 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 249,390 | $2,770,723 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 463,741 | $2,583,037 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 70,000 | $2,291,800 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 387,769 | $2,183,139 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 2,081,660 | $1,908,674 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 9,000 | $1,799,910 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 16,000 | $1,770,560 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 100,000 | $1,724,000 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 115,000 | $1,682,450 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 75,000 | $1,557,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 15,000 | $1,458,750 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 30,000 | $1,446,000 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 50,000 | $1,341,500 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 30,000 | $1,209,300 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 25,000 | $1,130,500 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 10,000 | $1,113,500 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 3,800 | $1,028,242 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 75,000 | $961,500 | dollars as filed | |
| ODDITY TECH LTD SHS CL A | M7518J104 | Stock | 70,000 | $936,600 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 50,000 | $932,000 | dollars as filed | |
| PELOTON INTERACTIVE INC | 70614W100 | CL A COM | 200,000 | $858,000 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 150,000 | $832,500 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 125,000 | $562,500 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 43,853 | $392,484 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 12,967 | $288,645 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 6,660 | $79,454 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-26-000003 | superseded | 2026-05-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001791827-26-000004 | this filing | 2026-05-28 | acceptance time not in the bulk data set |